ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,667.20
0.64%
Dow Jones
40,954.48
1.85%
US Dollar vs MXN
17.66134
-0.39%
Brent Oil
83.315
-1.22%
Bitcoin
64,452.01
-0.62%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Compugen Ltd (CGEN)

  7. Compugen Ltd (CGEN) Noticias

CGEN

Compugen (CGEN)

Compugen Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CGEN
FechaHoraFuenteTítuloSímboloCompañía
18/04/201606:14PR Newswire (US)Compugen Achieves Preclinical Milestone in Cancer Immunotherapy Collaboration With BayerNASDAQ:CGENCompugen Ltd
18/04/201606:08Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CGENCompugen Ltd
06/04/201606:00PR Newswire (US)Dr. Elliott Sigal Joins Compugen Ltd. as Strategic Advisor and Prof. Drew Pardoll Appointed Director at Compugen USA, Inc.NASDAQ:CGENCompugen Ltd
28/03/201606:00PR Newswire (US)Compugen to Present at the Jefferies Immuno-Oncology Summit in BostonNASDAQ:CGENCompugen Ltd
29/02/201606:00PR Newswire (US)Compugen Presents Results for CGEN-15029 Immuno-Oncology Therapeutic ProgramNASDAQ:CGENCompugen Ltd
09/02/201606:09PR Newswire (US)Compugen Ltd. Reports Fourth Quarter and Calendar 2015 ResultsNASDAQ:CGENCompugen Ltd
26/01/201606:00PR Newswire (US)Compugen Fourth Quarter and Yearend 2015 Conference Call Scheduled for Tuesday, February 9, 2016 at 10:00 AM ESTNASDAQ:CGENCompugen Ltd
11/12/201508:06Business WireCompugen Achieves Third Preclinical Milestone in Cancer Immunotherapy Collaboration with BayerNASDAQ:CGENCompugen Ltd
24/11/201506:00Business WireCompugen to Present at the Oppenheimer Healthcare Conference in New YorkNASDAQ:CGENCompugen Ltd
12/11/201506:00Business WireCompugen to Present at Jefferies 2015 Global Healthcare Conference in LondonNASDAQ:CGENCompugen Ltd
09/11/201506:00Business WireCompugen Presents Translational Study Results Supporting CGEN-15001 for the Treatment of Rheumatoid ArthritisNASDAQ:CGENCompugen Ltd
03/11/201506:00Business WireCompugen Ltd. Reports 3rd Quarter 2015 Financial ResultsNASDAQ:CGENCompugen Ltd
27/10/201506:52Business WireCompugen Third Quarter 2015 Conference Call Scheduled for Tuesday, November 3, 2015 at 10:00 AM ETNASDAQ:CGENCompugen Ltd
19/10/201506:00Business WireCompugen Discloses Antibody Drug Conjugate Program Results at the World ADC Summit in San DiegoNASDAQ:CGENCompugen Ltd
16/09/201506:00Business WireCompugen Discloses New Results Supporting CGEN-15052 as Novel Immune Checkpoint Target Candidate for Treatment of CancerNASDAQ:CGENCompugen Ltd
09/09/201506:00Business WireCompugen to Present at Upcoming Immuno-Oncology and Rheumatology ConferencesNASDAQ:CGENCompugen Ltd
04/08/201506:01Business WireCompugen Ltd. Reports 2nd Quarter 2015 Financial ResultsNASDAQ:CGENCompugen Ltd
27/07/201506:00Business WireCompugen Second Quarter 2015 Conference Call Scheduled for Tuesday, August 4, 2015 at 10:00 AM ETNASDAQ:CGENCompugen Ltd
15/06/201506:00Business WireCompugen to Present at JMP Securities Life Sciences Conference in New YorkNASDAQ:CGENCompugen Ltd
11/06/201508:09Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CGENCompugen Ltd
08/06/201506:07Business WireCompugen to Disclose Novel Cancer Immunotherapy Target Candidate & Comprehensive Target Characterization Infrastructure at To...NASDAQ:CGENCompugen Ltd
28/05/201506:00Business WireCompugen to Present at Jefferies 2015 Global Healthcare Conference in New YorkNASDAQ:CGENCompugen Ltd
27/05/201506:00Business WireCompugen to Hold Analyst and Investor Day in New YorkNASDAQ:CGENCompugen Ltd
05/05/201506:40Business WireCompugen Ltd. Reports First Quarter 2015 ResultsNASDAQ:CGENCompugen Ltd
28/04/201506:00Business WireCompugen First Quarter 2015 Conference Call Scheduled for Tuesday, May 5, 2015 at 10:00 AM ETNASDAQ:CGENCompugen Ltd
23/04/201503:51Analyst Ratings NetworkCompugen Research Coverage Started at Jefferies Group (CGEN)NASDAQ:CGENCompugen Ltd
14/04/201506:02Business WireCompugen Obtains Rights to Use Biological Systems and Materials from the US National Institutes of HealthNASDAQ:CGENCompugen Ltd
06/04/201506:10Business WireCompugen to Present at Two Immuno-Oncology Conferences in AprilNASDAQ:CGENCompugen Ltd
19/03/201506:09Business WireCompugen Announces Planned Relocation of Headquarters to Larger FacilitiesNASDAQ:CGENCompugen Ltd
12/03/201511:09Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CGENCompugen Ltd
 Showing the most relevant articles for your search:NASDAQ:CGEN

Su Consulta Reciente

USI
USTECH100
US Tech 100
PM
XAUUSD
Gold vs US Dollar
SPI
SP500
S&P 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
CVX
Chevron
COIN
ETHUSD
Ethereum
NYSE
BAC
Bank of America
NYSE
JPM
JP Morgan Chase
FX
EURMXN
Euro vs MXN
FX
EURUSD
Euro vs US Dollar
NYSE
DIS
Walt Disney
AMEX
XLF
Financial Select Sector
NYSE
XOM
Exxon Mobil
NYSE
MRK
Merck
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados